FDA
- Status: approved
Experimental continuous peripheral nerve blocks (Experimental continuous peripheral nerve blocks) regulatory status in United States.
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Yes. FDA has authorised it.
University of California, San Diego is the originator. The local marketing authorisation holder may differ — check the official source linked above.